Person:
ŞENOL, HALIL

Loading...
Profile Picture
Status
Organizational Units
Job Title
First Name
HALIL
Last Name
ŞENOL
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 13
No Thumbnail Available
PublicationMetadata only

Preclinical studies evaluating the therapeutic efficacy of novel natural compound olean-12-en-28-ol, 3β pentacosanoate for multiple sclerosis

2022-09-26, Şenol H., Özgün-Acar Ö., Dağ A., Eken A., Acar B., Aktaş Pepe N., Güner H., Aykut Z. G., Çevik Kaplan S., Ayaz Güner Ş., et al., ŞENOL, HALIL, DAĞ, AYDAN, TOPÇU, GÜLAÇTI

No Thumbnail Available
PublicationMetadata only

Synthesis, Characterization and Molecular Docking Studies of Highly Selective New Hydrazone Derivatives of Anthranilic Acid and Their Ring Closure Analogue Quinazolin-4(3H)-ones Against Lung Cancer Cells A549

2023-02-01, Tokalı F. S., Şenol H., Bulut Ş., Hacıosmanoğlu Aldoğan E., ŞENOL, HALIL

No Thumbnail Available
PublicationMetadata only

Novel Thiosemicarbazone and Thiazolidin‐4‐one Derivatives Containing Vanillin Core: Synthesis, Characterization and Anticancer Activity Studies

2023-01-01, Tokalı F. S., Şenol H., Dağ A., Gençoğlu Katmerlikaya T., Şendil K., ŞENOL, HALIL, DAĞ, AYDAN

No Thumbnail Available
PublicationMetadata only

Cytotoxic meroterpenoids from brown alga Stypopodium schimperi (Kützing) Verlaque & Boudouresque with comprehensive molecular docking & dynamics and ADME studies

2024-01-01, Demirkıran Ö., Erol E., Şenol H., Kesdi İ. M., Alim Toraman G. Ö., Okudan E. Ş., Topçu G., EROL, EBRU, ŞENOL, HALIL, ALİM TORAMAN, GÜLBAHAR ÖZGE, TOPÇU, GÜLAÇTI

No Thumbnail Available
PublicationMetadata only

Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent

2023-01-01, Şenol H., Özgün Acar Ö., Dağ A., Eken A., Güner H., Aykut Z. G., Topçu G., Şen A., ŞENOL, HALIL, DAĞ, AYDAN, TOPÇU, GÜLAÇTI

No Thumbnail Available
PublicationMetadata only

Synthesis, characterization, molecular docking and in vitro anti-cancer activity studies of new and highly selective 1,2,3-triazole substituted 4-hydroxybenzohyrdazide derivatives

2023-02-01, Şenol H., Ağgül A. G., Atasoy S., Güzeldemirci N., ŞENOL, HALIL, ATASOY, SEZEN

No Thumbnail Available
PublicationMetadata only

Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies

2023-09-01, Tokalı F. S., Şenol H., Yetke H. İ., Hacıosmanoğlu E., ŞENOL, HALIL, YETKE, HANDE İPEK, HACIOSMANOĞLU, EBRU

No Thumbnail Available
PublicationMetadata only

Novel Cholinesterase Inhibitors: Synthesis, Characterization, Molecular Docking, Dynamics and ADME Studies

2023-05-25, Şenol H., ŞENOL, HALIL

No Thumbnail Available
PublicationMetadata only

Synthesis of nitrogen-containing oleanolic acid derivatives as carbonic anhydrase and acetylcholinesterase inhibitors

2023-02-01, Şenol H., Çelik Turgut G., Şen A., Sağlamtaş R., Tuncay S., Gülçin İ., Topçu G., ŞENOL, HALIL

No Thumbnail Available
PublicationMetadata only

Novel Chalcone Derivatives of Ursolic Acid as Acetylcholinesterase Inhibitors: Synthesis, Characterization, Biological Activity, ADME prediction, Molecular Docking and Molecular Dynamics Studies

2023-10-01, Şenol H., Ghaffari-Moghaddam M., Alim Toraman G. Ö., Güller U., ŞENOL, HALIL, ALİM TORAMAN, GÜLBAHAR ÖZGE